Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SHPHthis companyShuttle Pharmaceuticals Holdings, Inc.	$5.10	-0.25×	1.31×	0×	-0.25×	-243.9%	0.0%	0.0%	0.0%	-519.9%	-460.8%	-321.6%	0.1×	0.01×	-168.25×	0.06×	0.0%	1	-1.02	2	B-
BBLGBone Biologics Corporation	$0.36	-0.55×	0.32×	0×	1.17×	1037.0%	0.0%	0.0%	0.0%	-57.8%	-60.2%	-158.0%	0×	1.72×	0×	13.85×	0.0%	1	-18.45	2	B-
BIVIBioVie Inc.	$1.35	-0.64×	0×	0×	397,772.85×	87659892.5%	0.0%	0.0%	0.0%	-0.0%	-0.0%	-135339.5%	0.03×	397,773.5×	-1,265.39×	3.59×	0.0%	2	-39.28	3	B
HSCSHeartSciences Inc.	$2.91	-0.56×	0.02×	1,185.36×	-275.91×	-25040.1%	-2982.1%	-194787.4%	-211666.5%	-4.1%	-0.2%	-145.9%	17.46×	-275.29×	-11.17×	0.53×	0.0%	1	-41.58	2	C
ISPCiSpecimen Inc.	$0.78	-0.11×	0.39×	0.62×	0.62×	-7973.6%	1.2%	-465.4%	-543.7%	-339.6%	-267.4%	-354.4%	0.09×	0.76×	-4,606.42×	1.12×	0.0%	2	-21.26	2	C
TOVXTheriva Biologics, Inc.	$0.16	-0.1×	0.17×	0×	0.33×	589.3%	0.0%	0.0%	0.0%	-164.1%	-52.1%	-653.9%	0.17×	0.44×	0×	1.74×	0.0%	2	-15.46	2	B-
Peer median	—	-0.55×	0.17×	0×	0.62×	589.3%	0.0%	0.0%	0.0%	-57.8%	-52.1%	-354.4%	0.09×	0.76×	-11.17×	1.74×	0.0%	2	-21.26	2	—